Work

Immunological dysregulation in polyendocrine metabolic ovarian syndrome: from immune-metabolic crosstalk to biomarkers and targeted therapies

Year: 2026
Type: article
Abstract: Polyendocrine metabolic ovarian syndrome (PMOS), formerly termed polycystic ovary syndrome (PCOS), encompasses heterogeneous reproductive and metabolic phenotypes. Immune dysregulation may amplify endocrine–metabolic dysfunction, but its direction, anatomical distribution, and causal importance remain uncertain. This narrative Mini Review integrates human observational evidence with animal and cell-based experiments and critically examines the implications for biomarkers and treatment. Human studies support altered nutrient-responsive inflammatory signaling and associations between adipose dysfunction, insulin resistance, and immune activation. However, ovarian findings cannot be reduced to generalized hyperinflammation: recent single-cell profiling suggests disruption of coordinated ovulatory immune communication alongside chronic inflammatory and extracellular-matrix programs. Experimental studies implicate macrophage–granulosa-cell interactions, androgen-sensitive inflammasome regulation, and the microbiota–bile acid–interleukin-22 axis, but these results establish mechanisms within particular models rather than causality in women. Interpretation is constrained by small or selected cohorts, inconsistent participant reporting, adiposity and treatment confounding, stimulated ovarian sampling, and limited external validation. Recent probiotic trials also illustrate the distinction between changes in surrogate markers and reproducible clinical benefit. No immune signature discussed here has sufficient evidence for routine diagnostic or treatment-selection use. Progress requires transparent population reporting, donor-level analyses, longitudinal and tissue-resolved studies, independent biomarker validation, and trials that prioritize reproductive and metabolic outcomes over isolated cytokine changes.
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7233860604
FWCI:
Cites: 51
Cited by:
Related to: 10